Video

Cancer Survivors Should Discuss COVID-19 Risks with Their Health Care Providers

Expert Dr. Sara Hurvitz discusses why cancer survivors should discuss their risk factors during the COVID-19 pandemic with their healthcare providers.

The new coronavirus, also called COVID-19, is particularly concerning for patients with cancer. However, survivors, while not as immunocompromised as those in active treatment, should still discuss their risk factors with their physicians to determine what, if any, extra precautions they should take.

At the 2020 Miami Breast Cancer Conference® and Educated Patient Breast Cancer Summit, CURE® spoke with Dr. Sara Hurvitz, an associate professor of medicine at the University of California, Los Angeles, about what questions survivors should ask their medical teams to stay safe during the pandemic.

Transcription:

I don’t think that most patients who are survivors who have already been treated for their breast cancer and are not currently on chemotherapy or other therapies that lower the white (blood cell) count, they’re not necessarily at a higher risk of developing it than other patients.

But it’s important to talk to one’s oncologist and primary care physician to gauge, based on my age, based on other medical conditions that I have, or based on the medications that I’m taking, how do you gauge what my risk is, and what activities should I avoid, or what activities am I OK to do?

Related Videos
Dr. Alan Tan is a genitourinary oncology (GU) and melanoma specialist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee; an associate professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center; and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Related Content